These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37580111)

  • 1. Development of oncolytic and gene therapy vectors based on adenovirus serotype 4 as an alternative to adenovirus serotype 5.
    Sallard E; Schulte L; van den Boom A; Klimovitskii A; Knierer J; Hagedorn C; Knocks M; Zhang W; Kreppel F; Ehrhardt A; Ehrke-Schulz E
    J Gene Med; 2024 Jan; 26(1):e3576. PubMed ID: 37580111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity when utilizing adenovirus serotype 4 and 5 vaccines expressing circumsporozoite protein in naïve and adenovirus (Ad5) immune mice.
    Schuldt NJ; Aldhamen YA; Godbehere-Roosa S; Seregin SS; Kousa YA; Amalfitano A
    Malar J; 2012 Jun; 11():209. PubMed ID: 22720732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy.
    Thirion C; Lochmüller H; Ruzsics Z; Boelhauve M; König C; Thedieck C; Kutik S; Geiger C; Kochanek S; Volpers C; Burgert HG
    Hum Gene Ther; 2006 Feb; 17(2):193-205. PubMed ID: 16454653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli.
    Hoffmann D; Wildner O
    BMC Biotechnol; 2006 Aug; 6():36. PubMed ID: 16887042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient mobilization of E1-deleted adenovirus type 5 vectors by wild-type adenoviruses of other serotypes.
    Rademaker HJ; El Hassan MAA; Versteeg GA; Rabelink MJWE; Hoeben RC
    J Gen Virol; 2002 Jun; 83(Pt 6):1311-1314. PubMed ID: 12029145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
    Wang H; Wei F; Li H; Ji X; Li S; Chen X
    Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease-deleted adenovirus vectors and complementing cell lines: potential applications of single-round replication mutants for vaccination and gene therapy.
    Oualikene W; Lamoureux L; Weber JM; Massie B
    Hum Gene Ther; 2000 Jun; 11(9):1341-53. PubMed ID: 10890743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transposon-assisted cloning and traceless mutagenesis of adenoviruses: Development of a novel vector based on species D.
    Ruzsics Z; Wagner M; Osterlehner A; Cook J; Koszinowski U; Burgert HG
    J Virol; 2006 Aug; 80(16):8100-13. PubMed ID: 16873266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenoviral Gene Therapy Vectors in Clinical Use-Basic Aspects with a Special Reference to Replication-Competent Adenovirus Formation and Its Impact on Clinical Safety.
    Leikas AJ; Ylä-Herttuala S; Hartikainen JEK
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species D Adenoviruses as Oncolytic Viral Vectors.
    Bullard BL; Corder BN; Weaver EA
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33291224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.
    Fallaux FJ; Bout A; van der Velde I; van den Wollenberg DJ; Hehir KM; Keegan J; Auger C; Cramer SJ; van Ormondt H; van der Eb AJ; Valerio D; Hoeben RC
    Hum Gene Ther; 1998 Sep; 9(13):1909-17. PubMed ID: 9741429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and assessment of human adenovirus type 11 as a gene transfer vector.
    Stone D; Ni S; Li ZY; Gaggar A; DiPaolo N; Feng Q; Sandig V; Lieber A
    J Virol; 2005 Apr; 79(8):5090-104. PubMed ID: 15795294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic image-guided liver cancer radiovirotherapy using dendrimer-coated adenovirus encoding the sodium iodide symporter as theranostic gene.
    Grünwald GK; Vetter A; Klutz K; Willhauck MJ; Schwenk N; Senekowitsch-Schmidtke R; Schwaiger M; Zach C; Wagner E; Göke B; Holm PS; Ogris M; Spitzweg C
    J Nucl Med; 2013 Aug; 54(8):1450-7. PubMed ID: 23843567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replication.
    Kawakami Y; Li H; Lam JT; Krasnykh V; Curiel DT; Blackwell JL
    Cancer Res; 2003 Mar; 63(6):1262-9. PubMed ID: 12649186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased Vector Gene Expression from E2b Gene-Deleted Adenovirus Serotype 5 Vaccines Intensifies Proinflammatory Immune Responses.
    Quiroga D; Aldhamen YA; Godbehere S; Harding L; Amalfitano A
    Clin Vaccine Immunol; 2017 Jun; 24(6):. PubMed ID: 28381403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Partial E3 Deletion in Replication-Defective Adenoviral Vectors Allows for Stable Expression of Potentially Toxic Transgene Products.
    Haut LH; Gill AL; Kurupati RK; Bian A; Li Y; Giles-Davis W; Xiang Z; Zhou XY; Ertl HC
    Hum Gene Ther Methods; 2016 Oct; 27(5):187-196. PubMed ID: 27604324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma.
    Wolkersdörfer GW; Morris JC; Ehninger G; Ramsey WJ
    J Gene Med; 2004 Jun; 6(6):652-62. PubMed ID: 15170736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted.
    Amalfitano A; Hauser MA; Hu H; Serra D; Begy CR; Chamberlain JS
    J Virol; 1998 Feb; 72(2):926-33. PubMed ID: 9444984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human adenovirus type 35: nucleotide sequence and vector development.
    Gao W; Robbins PD; Gambotto A
    Gene Ther; 2003 Nov; 10(23):1941-9. PubMed ID: 14528318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.